Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.: Social discussions and analytics

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Kenneth W Mahaffey, Johannes F E Mann, George Bakris, Florian M M Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, Richard Pratley,

July 2024 N Engl J Med

Synopsis of Social media discussions

Overall, the analysis shows a high level of enthusiasm and support for the research, with posts sharing detailed trial results such as lower risks of kidney events and cardiovascular mortality, and emphasizing the importance of this discovery, which is conveyed through assertive language like 'another win' and 'game-changer.' Words and tone reflect both scientific interest and optimism about the clinical impact.

Agreement

Moderate agreement

Most discussions support the positive findings and significance of the study, emphasizing that semaglutide is beneficial for CKD and diabetes patients.

Interest

High level of interest

Posts demonstrate high curiosity, often referencing major trials like FLOW and mentioning the implications for treatment, indicating eager engagement.

Engagement

High engagement

Discussions frequently include detailed mentions of results, trial design, and funding sources, showing deep involvement with the research findings.

Impact

High level of impact

Many posts highlight how this study could be a game-changer in nephrology and diabetes management, suggesting strong potential influence on future treatment approaches.

Social Mentions

YouTube

10 Videos

Bluesky

4 Posts

Facebook

10 Posts

Twitter

259 Posts

Blogs

14 Articles

News

316 Articles

Metrics

Video Views

58,617

Total Likes

1,108

Extended Reach

2,177,983

Social Features

613

Timeline: Posts about article

Semaglutide Saving Lives in Kidney Disease

GoggleDocs Education

August 14, 2024

35,412 views

Semaglutide's Impact on Kidney Health in Type 2 Diabetes Patients

Recent results from the FLOW study investigate the renal effects of semaglutide in patients with type 2 diabetes and chronic kidney disease. The study observed a 24% reduction in major kidney events and improved kidney and cardiovascular health.

Dra. Caty Duarte

June 13, 2024

9,993 views

Understanding the Impact of Weight Loss Drugs on Kidney Health and Heart Risks

This video explores the effects of GLP1 agonists like Ozempic and Mounjaro, originally designed for diabetes management, on weight loss and overall health. It highlights recent research showing semaglutide's ability to reduce kidney disease and cardiovascular risks in patients with type 2 diabetes.

Dr. Nene

January 8, 2025

3,920 views

Protecting the kidney with Ozempic

Endocrinology India

October 21, 2025

3,407 views

Insights on Kidney Transplant Advances from ERA 2024 Congress

In a special webinar in cooperation between MARKUS HOMe and Nephrology Dialysis and Transplantation, experts discuss landmark studies from the ERA 2024 convention in Stockholm. The focus includes the promising results of felzartamab in treating antibody-mediated rejection in kidney transplants.

MARKUS at HOMe

May 31, 2024

2,906 views

Effects of Semaglutide on Kidney Disease in Patients with Type 2 Diabetes

Prof Johannes Mann presents the FLOW study results demonstrating the nephroprotective effects of Semaglutide in 3533 chronic kidney disease patients, emphasizing recent advances in managing blood pressure in CKD.

MARKUS at HOMe

May 25, 2024

2,226 views

Evaluating Cardiovascular Safety of Tirzepatide vs. Dulaglutide

This podcast covers vulnerable plaque, industry payments to trainees, and the trial design of tirzepatide versus dulaglutide. Insights on major adverse cardiovascular events in type 2 diabetes patients are discussed, focusing on the ongoing analysis of over 13,000 participants in this important study.

Medscape

July 19, 2024

546 views

Semaglutide's Renal Benefits in Type 2 Diabetes Patients

The study FLOW investigates the renal effects of semaglutide in patients with type 2 diabetes and chronic kidney disease, showing a 24% reduction in major kidney events and improved kidney and cardiovascular health.

Dra. Caty Duarte

June 13, 2024

90 views

Semaglutide's Protective Effects on Kidney Disease in Type 2 Diabetes

Semaglutide reduces risks of kidney failure, cardiovascular problems, and death in patients with type 2 diabetes and chronic kidney disease, showing significant improvements in kidney health and slowing disease progression based on clinical trial data.

Dr. Minh Do

October 29, 2024

62 views

Exploring Quantum Mechanics: Fundamental Principles Explained

This video delves into the core concepts of quantum mechanics, focusing on fundamental principles that govern the behavior of matter and energy at microscopic scales. Viewers will gain insights into wave-particle duality, superposition, and entanglement.

社團法人台灣家庭藥師學會

June 26, 2024

57 views

Archangel Beth
@archangelbeth.bsky.social (Bluesky)

Nope! Article links to a few places but the first screenshot seems to be one of the studies. The next three are excerpts from the NatGeo human trials.
view full post

November 16, 2025

2
Bookdasa
@Totoro19514032 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 30, 2025

42
Ahmed Al-Za'abi
@AhZabi (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 27, 2025

42
JJ
@jjogodsz (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Sovichia@789
@Sovichia1993 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Syed Shahrul Naz
@drshahrul80 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
imran robleh
@imran_rob (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Gary Deed
@garydeed (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
jorge gamboa
@jorgega62811906 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
MetaboliccareToday.com
@MetabolicCare (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Victor De La Espriella Badel
@vimadelaeb (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
ResearchPulse
@ResearchPulse1 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Sharona Azriel
@SharonaAzriel (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Wimen
@1a31551c566e43d (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
abhimanyu singh
@SardarAbhimanyu (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Frankie
@pacovelascor (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Sayantan Mukherjee
@hopelessweirdo (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Abdulmohsen bakhsh د .عبدالمحسن بخش
@amohsenbakhsh (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Yanamandra Sastri
@Yanamandra70982 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
moath saleh
@moathsaleh (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
JOON T
@TubuloToxic (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 24, 2025

42
Jamie Wang
@jamiewang1228 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
araceli miranda
@amiraveg (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Niranjan Ganesh
@Drniran (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Carolina Glz Fuentes
@karolas_smile (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Abhishek
@aksrulz13 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Jorge Luis Rodríguez .
@JL____Rodriguez (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
MaFer Zavala
@Mafer_ZavalaM (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Chih-Yao Hsu
@reclast (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Roberto Gutiérrez
@DrRobertoGuti (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Katty Rivera
@KattyRiveraG (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Dr Jorge Ferradas Solar
@JorgeFerradasSo (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Serigne_Fall
@fallserigne34 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Joyce Bwombengi
@kemuntoMD (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Kidneyman
@Kidneyman5 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Layla Omar
@hlaylaomar (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Gabriel D.C.
@GabDavC (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
木下卓哉
@tSMAJ2uzxBX1hoH (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Joel M. Topf, MD FACP
@kidney_boy (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Ye M. Tun, MD FACP
@DrYeMyintTun (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Anjana Gopal, MBBS, MD, DM Nephrology, FASN
@AnjanaGopal9 (Twitter)

RT @edgarvlermamd: Effects of Once-Weekly
view full post

October 23, 2025

42
Edgar V. Lerma
@edgarvlermamd (Twitter)

Effects of Once-Weekly
view full post

October 23, 2025

113
42
Edgar V. Lerma
@edgarvlermamd.bsky.social (Bluesky)

Effects of Once-Weekly Semaglutide #Nephpearls #Cardiorenal #NephSky
view full post

October 23, 2025

2
Edgar V. Lerma
@edgarvlermamd (Twitter)

Effects of Once-Weekly Semaglutide #Nephpearls #Cardiorenal #VisualAbstract by @AnjanaGopal9 @kidney_boy @brian_rifkin FLOW
view full post

October 23, 2025

1
Christos Argyropoulos MD PhD 0kale/acc
@ChristosArgyrop (Twitter)

RT @5_utr: The FLOW trial. Nephrologists don’t mess around with their trial acronyms do they @ChristosArgyrop at least it’s not the Kidney…
view full post

August 24, 2025

1
M. Bolton
@5_utr (Twitter)

The FLOW trial. Nephrologists don’t mess around with their trial acronyms do they @ChristosArgyrop at least it’s not the Kidney disease Advancement Limiting Experiment (KALE) trial https://t.co/UN6EViq9QY
view full post

August 23, 2025

3
1
3DArms
@3DArms (Twitter)

@DrTurdFerguson_ If by "cook" you mean "improve the health of, then yes. "The risk of a primary-outcome event was 24% lower in the semaglutide group than in the placebo group" https://t.co/oCSTscRqQI
view full post

July 27, 2025

5
boss charles
@rockstopher2 (Twitter)

@ClickingSeason Except in the studies, even when you didn’t control for diet, the people were healthier. The fat and excess is the main problem, more so than the diet https://t.co/3MOOcmN0rP
view full post

July 6, 2025
boss charles
@rockstopher2 (Twitter)

@IterIntellectus Actually in the studies people who took ozempic were healthier irregardless of what they ate https://t.co/3MOOcmNyhn It’s the fat
view full post

July 5, 2025
Andrés Felipe Cárdenas Velásquez
@anthrexmde (Twitter)

DOI: 10.1056/NEJMoa2403347
view full post

June 28, 2025

9
Mounir Basalus (Ⲃⲁⲥⲓⲗⲓⲟⲥ)
@Basalus (Twitter)

3/
view full post

May 29, 2025

1
Joyce Bwombengi
@kemuntoMD (Twitter)

RT @mvaduganathan:
view full post

May 27, 2025

307
Jiyeon
@grantinlight (Twitter)

RT @EricTopol: How to reduce deaths and kidney disease in patients with Type 2 diabetes? Report of a new GLP-1 randomized trial @NEJM https…
view full post

May 15, 2025

46
International Obesity Alliance
@ObesityInt (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 10, 2025

21
Madhav Jha
@MadhavJ64080943 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 10, 2025

21
Mohammad Aleidi
@aleidimed (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 10, 2025

21
Raul Ernesto Reyes Sanchez
@ringo710828 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 10, 2025

21
AngryPhDstudent❗️❗️❗️
@ONNESHA092 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 10, 2025

21
Dr Alo, DO, FACC
@MohammedAlo (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
HUGO COLOMBO MD
@HCOLOMBO1958 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
diacavan
@diacavan (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Dr Celestino Gutiérrez González MD
@CelestinoGutirr (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Sid Mengi, MD, MRCP
@sidmengi_dr (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Dr.Rajiv Sankaranarayanan
@DrRajivsankar (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Carlos Maiorana
@MaioranaCarlos (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
EOLO MORANDI JR.
@eolojr (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Dr.Ezhil Mugunthan
@Ezhil_mugunthan (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
ALKINDY Abdulrhman
@Abdul_alkindy (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Rafael Radaeli
@rfradaeli (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Mohammad saleem baba.MBBS, MD, DM
@drsaleembaba (Twitter)

https://t.co/2PTlGmKgZe
view full post

May 9, 2025

1
Mark Luedde
@LuddeMark (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
shaffy
@shaffy8585 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Leela Rao
@DrLeelaEndo (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

May 9, 2025

21
Ahmed Bennis MD
@drbennisahmed (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease https://t.co/c7AuTCM7He https://t.co/kRPGFfbq3E
view full post

May 9, 2025

71
21
Omid Hakami Hakami
@Omidhakami (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 3, 2025

7
AFARPA
@AfarpaAlicante (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 3, 2025

7
Maria Queralt Gorgas
@qgorgas (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 3, 2025

7
Manu Morales Sánchez
@Manumoraless (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 2, 2025

7
CIMES
@cimesalvador (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 2, 2025

7
MJP
@_Mywonderfulife (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 2, 2025

7
Juan Manuel Núñez
@Juanma_JMNC (Twitter)

RT @FarmaMadridAP: (JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 t…
view full post

April 2, 2025

7
Farmacia Madrid AP
@FarmaMadridAP (Twitter)

(JAMA) La FDA aprueba semaglutida para reducir el riesgo de progresión de la enfermedad renal, https://t.co/tCm26QQvS6 tras los resultados del EC https://t.co/Ky8ct5u2bC
view full post

April 2, 2025

18
7
Ernesto Yar
@YarErnesto (Twitter)

RT @gabi_puchepalao:
view full post

April 1, 2025

12
carlos gutierrez
@nefrogastro (Twitter)

RT @NefroClassMx: Semaglutida ↓ eventos renales mayores en DM2+ERC (↓ ≥50% eGFR, ERT, eGFR <15, o muerte renal/cardiovascular.) (HR 0.76; I…
view full post

April 1, 2025

3
Marco MF
@MarcoMF7 (Twitter)

RT @NefroClassMx: Semaglutida ↓ eventos renales mayores en DM2+ERC (↓ ≥50% eGFR, ERT, eGFR <15, o muerte renal/cardiovascular.) (HR 0.76; I…
view full post

April 1, 2025

3
Memin
@96king_of_f (Twitter)

RT @NefroClassMx: Semaglutida ↓ eventos renales mayores en DM2+ERC (↓ ≥50% eGFR, ERT, eGFR <15, o muerte renal/cardiovascular.) (HR 0.76; I…
view full post

March 31, 2025

3
Mr Morfeo
@mr_morfeo000 (Twitter)

RT @NefroClassMx: Semaglutida ↓ eventos renales mayores en DM2+ERC (↓ ≥50% eGFR, ERT, eGFR <15, o muerte renal/cardiovascular.) (HR 0.76; I…
view full post

March 31, 2025

3
NefroClass
@NefroClassMx (Twitter)

Semaglutida ↓ eventos renales mayores en DM2+ERC (↓ ≥50% eGFR, ERT, eGFR <15, o muerte renal/cardiovascular.) (HR 0.76; IC95% 0.66–0.88; p=0.0003). También ↓ MACE (HR 0.82) y mortalidad total (HR 0.80). Menos EA graves (49.6% vs 53.8%). NEJM 2024. DOI: 10.1056/NEJMoa2403347 https://t.co/qabmHKswJo
view full post

March 31, 2025

7
3
Carlos Vergara
@chiwiperreo_14 (Twitter)

RT @gabi_puchepalao:
view full post

March 31, 2025

12
Mariangela Pereira
@MariangelaP1 (Twitter)

RT @gabi_puchepalao:
view full post

March 31, 2025

12
ong beng hooi
@ongbenghooi1 (Twitter)

RT @gabi_puchepalao:
view full post

March 31, 2025

12
diacavan
@diacavan (Twitter)

RT @gabi_puchepalao:
view full post

March 31, 2025

12
Almansour
@malmansour81 (Twitter)

RT @gabi_puchepalao:
view full post

March 31, 2025

12
Carlos Palacio
@CAPE1223 (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
Sebastián Tenorio Vargas
@SebasTenorio (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
HUGO COLOMBO MD
@HCOLOMBO1958 (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
EOLO MORANDI JR.
@eolojr (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
Ramon Lozano
@Moonch0105 (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
Juan Manuel Núñez
@Juanma_JMNC (Twitter)

RT @gabi_puchepalao:
view full post

March 30, 2025

12
Gabriel Puche, MD/PhD
@gabi_puchepalao (Twitter)

view full post

March 30, 2025

41
12
Cadence Diachikova
@CDiachikova (Twitter)

RT @mvaduganathan:
view full post

March 17, 2025

307
Kakrotosh
@Kakrotosh (Twitter)

@tracewoodgrains We just need to get these mother fuckers on ozempic and later maybe retatrutide. https://t.co/rWpOk9Wbls
view full post

March 15, 2025

1
高槻病院・井上病院・しんあいクリニック　総合内科
@Takatsuki_GIM (Twitter)

セマグルチド、CKD+2型糖尿病に有効 https://t.co/Z5E19hAUR0 FLOW試験主要腎イベント↓24%（HR 0.76, 95%CI 0.66-0.88）心血管死↓29%（HR 0.71, 95%CI 0.56-0.89）腎機能低下抑制＆死亡率改善。 GLP-1RAはCKDの新たな治療選択肢に https://t.co/VWJpxPdckY
view full post

February 25, 2025

4
Badwan
@abd0badwan (Twitter)

Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. https://t.co/R0oEq1DX7V https://t.co/zr4PkCbLef
view full post

February 20, 2025
Powell Kafwanka, MBChB, MSc
@PowellKafwanka (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 30, 2025

8
Dr. ALCupich
@alcupich (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
EOLO MORANDI JR.
@eolojr (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
Hany Ragy
@Hragy (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
R A Popalzai
@Radion_Popalzai (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
AngryPhDstudent❗️❗️❗️
@ONNESHA092 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
Everardo J. Díaz-López
@Everardox2 (Twitter)

RT @drbennisahmed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clini…
view full post

January 29, 2025

8
Jamie Pollock MD
@JamiePollo56820 (Twitter)

RT @JamiePollo56820: @MichaelAlbertMD The FLOW trial, which investigated the effects of semaglutide on chronic kidney disease in patients w…
view full post

January 29, 2025

1
Jamie Pollock MD
@JamiePollo56820 (Twitter)

@MichaelAlbertMD The FLOW trial, which investigated the effects of semaglutide on chronic kidney disease in patients with type 2 diabetes, was funded by Novo Nordisk, the manufacturer of semaglutide. The company managed trial operations and conducted the analyses, which were independently
view full post

January 29, 2025

1
Ahmed Bennis MD
@drbennisahmed (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease https://t.co/c7AuTCM7He https://t.co/GjY9QeHjDd
view full post

January 29, 2025

26
8
markusathome
@MarkusAtHome (Twitter)

TOP 1: FLOW by Drs. @VladoPerkovic, @RpratleyMD et al. https://t.co/ULuWhRzsBA In patients with type 2 diabetes and chronic kidney disease, semaglutide reduced CKD progression and cardiovascular death. https://t.co/VsE2mQV4u6
view full post

January 18, 2025

3
Saludteca
@Saludteca (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/Dj9dXBWeEf
view full post

January 15, 2025
Juan Carlos Obaya
@jcobaya69 (Twitter)

RT @NEJM: Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significant…
view full post

January 14, 2025

8
Johns Hopkins Frailty Science #FrailtyFighter
@FrailtyScience (Twitter)

RT @NEJM: Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significant…
view full post

January 14, 2025

8
Carmelo Espinosa M.D.
@carmelografo (Twitter)

RT @NEJM: Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significant…
view full post

January 14, 2025

8
NEJM.org
@nejm.org (Bluesky)

view full post

January 14, 2025

20
10
Habib Cissé
@Kissiland_man (Twitter)

RT @NEJM: Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significant…
view full post

January 14, 2025

8
NEJM
@NEJM (Twitter)

Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. https://t.co/Q9DAA6mPte https://t.co/eH0XIgTnmO
view full post

January 14, 2025

47
8
Emily Mason
@EmilyMason1192 (Twitter)

@totalimmunity @BEisenhart You have a conspiracy between the NEJM and the Economist, and I can easily find others. That's crazy. https://t.co/pBPOR4VCLe
view full post

January 3, 2025
Emily Mason
@EmilyMason1192 (Twitter)

@thejeebuzcrust @SideGravy @DavidLund6 @BEisenhart That is not a source. One of my sources is NEJM, which is independent. There is no way that conspiracy mongers will trust science, but for others. https://t.co/pBPOR4VCLe
view full post

January 3, 2025

8
Ramón Inti
@boliviamarka (Twitter)

RT @Inaaqc_bo: ATEROMA (ASOBAT)|
view full post

January 2, 2025

1
Ted Kyle
@ConscienHealth (Twitter)

RT @Obesidades_mx: @ConscienHealth -Perkovic V, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N…
view full post

December 27, 2024

1
Obesidades México
@Obesidades_mx (Twitter)

@ConscienHealth -Perkovic V, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024. -Packer M, et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2024.
view full post

December 27, 2024

1
1
@Inaaqc_bo (Twitter)

ATEROMA (ASOBAT)|
view full post

December 24, 2024

1
1
Harmless Frog
@FrogHarmless (Twitter)

@bulkbiker @DrEenfeldt You simply are unaware of the evidence. There are two 4-year trials showing it's beneficial for staying alive and healthy. Yes, there are adverse effects, but IMO they aren't even close to outweighing the benefits. https://t.co/g01mND2nzh https://t.co/m4HlNPuhj8
view full post

December 21, 2024

1
Omdeep Pabla
@Omdeep_Pabla (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 19, 2024

9
Alegu
@alegujunior (Twitter)

3/14 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes... https://t.co/ilO4yYmp4E
view full post

December 19, 2024
choiLab
@jungminchoilab (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 18, 2024

9
gustavoreyesl
@gustavoreyesl (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 18, 2024

9
Kurikesh George
@Kurikesh (Twitter)

RT @DrAkhilX: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZC…
view full post

December 18, 2024

7
morgado
@alemorgadooo (Twitter)

RT @DrAkhilX: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZC…
view full post

December 18, 2024

7
|حسن||hassan|
@7asn_Anwar (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes 2 https://t.co/7t3A1twi9h
view full post

December 18, 2024
SpaceAix
@cathcoste (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 18, 2024

9
Ljubomir Josifovski
@ljupc0 (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 18, 2024

9
SAMUEL ADEGBOLA
@SAMUELADEGBOL17 (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 18, 2024

9
Dr NAGA SHASHIKANTH P
@NagaShashikanth (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 17, 2024

9
Dr. Xs （Fuu）Artificial Life Intelligence The I
@_x_ai_i (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 17, 2024

9
Dr. S Dennis NYANZI
@NSengoobaa (Twitter)

RT @DrAkhilX: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZC…
view full post

December 17, 2024

7
กอ |
@zyekonim (Twitter)

RT @DrAkhilX: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZC…
view full post

December 17, 2024

7
Stephen A. Boyd, Ph.D.
@StephenABoydPh1 (Twitter)

RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
view full post

December 17, 2024

9
Samuel Hume
@DrSamuelBHume (Twitter)

Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (https://t.co/m7Mo9hEruE), kidney disease (https://t.co/acauBtOjVt), osteoarthritis (https://t.co/8GcpZybcHh), heart failure (https://t.co/oulxMcXNco), and
view full post

December 17, 2024

57
9
Juan Manuel Núñez
@Juanma_JMNC (Twitter)

RT @DrAkhilX: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZC…
view full post

December 17, 2024

7
Dr. Akhil
@DrAkhilX (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/3NiRyNwBuU https://t.co/zhZCTiLFA5
view full post

December 17, 2024

63
7
Martín López de la Torre
@elendocrino (Twitter)

RT @CristobMorales: https://t.co/8KCpwiOS77 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Directamente…
view full post

December 16, 2024

2
Luis Tobajas Belvís
@luisotobajas (Twitter)

RT @CristobMorales: https://t.co/8KCpwiOS77 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Directamente…
view full post

December 14, 2024

2
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro (Twitter)

RT @jorgericof: Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Eff…
view full post

December 13, 2024

5
Lorendiz Ronca
@LorendizR (Twitter)

RT @jorgericof: Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Eff…
view full post

December 13, 2024

5
JorgeEdoChava75
@QicenoJorge (Twitter)

RT @jorgericof: Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Eff…
view full post

December 13, 2024

5
Vanessavillavicencio
@elba_vanessa (Twitter)

RT @jorgericof: Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Eff…
view full post

December 13, 2024

5
Maria Jose Soler
@PepaSolerR (Twitter)

RT @jorgericof: Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Eff…
view full post

December 13, 2024

5
Dr Jorge Rico Fontalvo. MD.FISN. FSLANH , PhD
@jorgericof (Twitter)

Carta al editor . Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Tomas Rodríguez-Yánez, María J. Soler, published the paper: Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. Nefrología Latinoamericana @PepaSolerR https://t.co/0MgR3DuAxT https://t.co/7nssxCnsmG
view full post

December 13, 2024

29
5
Cristobal Morales
@CristobMorales (Twitter)

https://t.co/8KCpwiOS77 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Directamente del @NEJM a la Ficha técnica… cuando la ciencia acerca la innovación a los pacientes #FLOWtrial @NovoNordiskES https://t.co/pDxekt9CII https://t.co/MmZQ24J5yz
view full post

December 13, 2024

3
2
@ZKForTre (Twitter)

6. If by benefits of the drug you mean weight, glycemic, cardiac, renal, vascular, and OA (among other forthcoming indications), the impacts are persistent: https://t.co/mPQur3Hjzy https://t.co/p4k8UTTuMQ https://t.co/XNvGAzKWur https://t.co/dvV9IH2EHE https://t.co/BHSslgz3Xr
view full post

December 12, 2024

12
Chandralekha
@Chandra12962937 (Twitter)

RT @Vasuragh: We participated in a FLOW Study on effects of Semaglutiden on CKD. It was an amazing experience working and contributing. h…
view full post

December 5, 2024

3
Michael Fralick
@FralickMike (Twitter)

#3 with @altmetric score of 2826 and 110 citations, semaglutide makes another appearance! Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. Another game changer. Patients with type 2 diabetes and CKD randomized to semaglutide had a 4% absolute
view full post

December 4, 2024
Aryan Biwalkar
@AryanBiwalkar (Twitter)

RT @Vasuragh: We participated in a FLOW Study on effects of Semaglutiden on CKD. It was an amazing experience working and contributing. h…
view full post

December 3, 2024

3
Girish Ramrao Jadhavrao
@girishj100 (Twitter)

RT @Vasuragh: We participated in a FLOW Study on effects of Semaglutiden on CKD. It was an amazing experience working and contributing. h…
view full post

December 3, 2024

3
Vasundhara Raghavan
@Vasuragh (Twitter)

We participated in a FLOW Study on effects of Semaglutiden on CKD. It was an amazing experience working and contributing. https://t.co/IeipPcitEu https://t.co/cdckobnY69
view full post

December 3, 2024

6
3
Niranjan Ganesh
@Drniran (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. - Kidney International Reports https://t.co/IKOqCWHvHA
view full post

December 1, 2024
myrddin
@myrddindude (Twitter)

@feafij @Rohanburdened @est_magnetique @clairlemon “Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease.” Funded by Novo Norodisk, but this study shows semaglutide reducing kidney issues. https://t.co/t9q1xeDMmn
view full post

November 26, 2024

1
Hormonal Well-Being
@Hormonal_WB (Twitter)

The 3rd surprising benefit of GLP1s--they can improve kidney function! https://t.co/stj8HbNVwU #GLP1 #tirzepatide #semaglutide Stay tuned for 7 more benefits! From Hormonal Well-Being 713-714-7523 https://t.co/fsHSEdYsVm
view full post

November 25, 2024
Kaypee777
@Kaypee7771 (Twitter)

@daley63965 @Nallysmom @DrSyedHaider @naomirwolf https://t.co/BL1GtBQMwJ Conclusions: Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease
view full post

November 23, 2024
Leonli
@Leonlee287 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

November 18, 2024

106
Arpit Gupta
@arpitrage (Twitter)

@otis_reid The kidney disease savings could big, but of course the drugs cost a lot too https://t.co/jrxNAq5ZR9
view full post

November 14, 2024

2
にいやん
@niiyan51 (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/jrTkHVbeqh
view full post

October 27, 2024
Mae Ellis
@EllisMae555 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

September 16, 2024

44
慢性腎臓病のお医者さん
@jinzou2024 (Twitter)

GLP-1受容体作動薬のセマグルチドの腎保護作用が報告されました。2型糖尿病の慢性腎臓病患者さんの治療薬がまた１つ増えましたね。RAS阻害薬しかなかった時代からこの10年で大きく変わりました。 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
view full post

September 9, 2024

2
Rénif
@Renif_idf (Twitter)

RT @com_SFNDT:
view full post

September 5, 2024

1
SFNDT
@com_SFNDT (Twitter)

view full post

September 4, 2024

3
1
Roberto Arcadio
@Robertoarcadio_ (Twitter)

RT @ValleAlfonso:
view full post

August 5, 2024

27
redGDPS Diabetes
@redGDPS (Twitter)

Acceso a bibliografia comentada en @PubMedOnline https://t.co/40RYnRHgTW
view full post

July 25, 2024
redGDPS Diabetes
@redGDPS (Twitter)

Full text links Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Authors: Vlado Perkovic, M.B. et al https://t.co/57Xs3ldD6q Resumen disponible en formato pdf
view full post

July 25, 2024
旅人 tabito
@tabibito250 (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/FIeohLrexf
view full post

July 16, 2024

1
Dr Hanan asad MD
@RealDrAsad (Twitter)

view full post

July 16, 2024

1
Gonzalo Bautista Prieto. MD
@GonzalBautistaP (Twitter)

RT @ASPNeph: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/A36c3DA8Au #CKD @NEJM
view full post

July 14, 2024

3
もっぷ
@chorusmoppu (Twitter)

RT @dr_ukio: ★FLOW試験の結果がERA /NEJMで同時発表されました！ 2型DM+CKD (eGFR 25-75 / UACR 100-5000)　3533人(66歳、アジア24%) セマグルチド注射1.0mg vs プラセボ 3.4年主要複合イベント(…
view full post

July 14, 2024

4
diacavan
@diacavan (Twitter)

RT @ASPNeph: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/A36c3DA8Au #CKD @NEJM
view full post

July 13, 2024

3
木下卓哉
@tSMAJ2uzxBX1hoH (Twitter)

RT @ASPNeph: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/A36c3DA8Au #CKD @NEJM
view full post

July 13, 2024

3
American Society of Pediatric Nephrology
@ASPNeph (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/A36c3DA8Au #CKD @NEJM
view full post

July 13, 2024

5
3
Abdallah Al-Mohammad
@AAlMohammad87 (Twitter)

It is noted that discontinuation of #Semaglutide or placebo in the #FLOW trial occurred in 26% of the patients, while adherence rate was 89% @BSHeartFailure @Ahmed742Iqbal @NEJM @SheffieldHosp @RCPEdin #CardioTwitter https://t.co/TeQA3FamsO
view full post

July 13, 2024

1
Pablo Portocarrero
@portorenal (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 13, 2024

44
旅人 tabito
@tabibito250 (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/FIeohLrexf
view full post

July 13, 2024

1
DiabetoPitie
@DiabetoPitie (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
Giovanni Salamano
@SalamanoMD (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/g6yWh82iP3
view full post

July 12, 2024
José Guzmán Esquivel MD.
@jguzmanesquivel (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/aZta87C9il
view full post

July 12, 2024

1
Tom Hsiung
@TomHsiung (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/fNilmF6gvh
view full post

July 12, 2024
George Kolostoumpis
@gkolost (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
nadjib kaouache
@KaouacheNa98963 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
Lyzinhawer Alza
@LyzinhawerA (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
青木秀輔
@Shusuke_AOKI (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
Dr yassine benfdil
@Yasbenf (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 12, 2024

44
Paul Williams
@PaulWillBirds (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Alketa Koroshi
@gjyshiketa (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/KPL6mbrDYi
view full post

July 11, 2024
Powell Kafwanka, MBChB, MSc
@PowellKafwanka (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
ForensicPsyMD
@ForensicPsyMD (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/iBt7FOgQpn
view full post

July 11, 2024
Manuel Méndez
@mendez_bailon (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Arsene Mekinian
@mekinian2 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
BMJ Open Diabetes Research & Care journal
@DiabetesRC (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Marcia S Newman
@marciasgreen (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Manoj Mayogi Mishra
@mayogisense (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Laura Letona
@Lletonag (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Dr. Sou
@SwissHeartDoc (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Laly
@SANDRALILIANAB3 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
ดยองงี่ แฮริสันฉันจะต้มนายกิน
@lookscanBDCvin (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Mehdi Maanaoui
@MaanaouiMehdi (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
EOLO MORANDI JR.
@eolojr (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Kent Doi
@kentdoi (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/OzmtjBZOYJ
view full post

July 11, 2024

2
Roger Smith, Operations Director
@augmentinabuser (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Graham Abra, MD
@GrahamAbra (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
Chris Hill
@dochill82 (Twitter)

RT @NEJM: Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) https://t.co/Q9DAA6mPt…
view full post

July 11, 2024

44
B i y o t e k n o l o j i
@Biyoteknolojitr (Twitter)

https://t.co/4OShH6gENg
view full post

July 10, 2024
@CKD_ce
@ckd_ce (Twitter)

3) This program focuses on the #FLOW trial recently published in the @NEJM by @VladovPerkovic: Effects of #Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes, at https://t.co/sKuZ162ATj.
view full post

July 9, 2024

3
Carmen Milagros Resto Quintero
@MilagrosRe11568 (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/CURAQY1icw
view full post

June 25, 2024
Joshua Neumiller
@JoshuaNeumiller (Twitter)

RT @P_Rossing: Presentation of FLOW today @ADA in Orlando with New data so stay tuned! Effects of Semaglutide on Chronic Kidney Disease in…
view full post

June 24, 2024

3
Cristina Legido-Quigley
@DrLegidoQuigley (Twitter)

RT @P_Rossing: Presentation of FLOW today @ADA in Orlando with New data so stay tuned! Effects of Semaglutide on Chronic Kidney Disease in…
view full post

June 24, 2024

3
Peter Rossing
@P_Rossing (Twitter)

Presentation of FLOW today @ADA in Orlando with New data so stay tuned! Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/gCN7bwbOhO
view full post

June 24, 2024

10
3
いっそくとび
@statandnow (Twitter)

腎臓にもよい。今までは心血管イベントが主要アウトカムのRCTしか結果がなかったのかな？ T2DMのある患者のCKDに対するセマグルチドの効果 https://t.co/TJuNz5qivO
view full post

June 23, 2024

2
たけちゃん
@nitrotake (Twitter)

FLOW study https://t.co/RNV8FbNCCX
view full post

June 17, 2024
YD_AUSTRIA
@YD_AUT (Twitter)

Link zur Publikation: https://t.co/LgXbUzokYJ
view full post

June 16, 2024

1
Nephrology Journal Club
@NephJC (Twitter)

2/10 What did I miss? In trials of CV outcomes, GLP-1 agonists have shown promise in reducing proteinuria. The FLOW trial evaluated the use of semaglutide in reducing major adverse kidney outcomes (MAKE) in patients with CKD and DM2. https://t.co/464escIi4g
view full post

June 13, 2024
AKHOMM
@kidneymedmgmt (Twitter)

FLOW is the first primary kidney outcome trial of a GLP1-RA. Semaglutide demonstrated a lower risk of kidney events, cardiovascular events, and all-cause mortality compared to placebo. https://t.co/QcMB5JwoKw
view full post

June 12, 2024

2
Brammah Thanga
@brammahin (Twitter)

RT @NephJC: Do not forget to look at the @NEJM article before we start. Click the
view full post

June 12, 2024

1
Nephrology Journal Club
@NephJC (Twitter)

Do not forget to look at the @NEJM article before we start. Click the
view full post

June 12, 2024

2
1
DailyHemo
@DailyHemo (Twitter)

Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. https://t.co/6NA5YBNLz4 #ckd #diabetes #health #medicine
view full post

June 12, 2024
Nephrology Journal Club
@NephJC (Twitter)

Do not forget to look at the @NEJM article before we start. Click the
view full post

June 11, 2024

3
Brian Rifkin, MD
@brian_rifkin (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 11, 2024

8
Joel M. Topf, MD FACP
@kidney_boy (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 8, 2024

8
diacavan
@diacavan (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 8, 2024

8
Dr. Ronald Caraballo NEFROLOGO
@ronald_nefro (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 8, 2024

8
Santiago Moreno T.
@santy431 (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 7, 2024

8
Nephrology Journal Club
@NephJC (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 7, 2024

8
Elba Medina
@elbaonelida (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 7, 2024

8
Swapnil Hiremath @hswapnil.medsky.social
@hswapnil (Twitter)

RT @dra_miliflores: Ready for #NephJC discussion✅
view full post

June 7, 2024

8
Milagros Flores
@dra_miliflores (Twitter)

Ready for #NephJC discussion✅
view full post

June 7, 2024

14
8
Pon｜食と健康
@PonNutr (Twitter)

糖尿病および慢性腎症患者に対するGLP-1作動薬（セマグルチド）の腎不全、心血管イベント、死亡リスクの低減効果（New Engl J Med） ☑︎ セマグルチド1700人、プラセボ1700人の大規模RCTで追跡期間の中央値は3.4年 ☑︎ 各アウトカムのリスクは軒並み約20％低減した https://t.co/7ZeTK6JbwT
view full post

June 4, 2024

2
たけちゃん
@nitrotake (Twitter)

2型糖尿病のCKDに対するセマグルチド https://t.co/RNV8FbNCCX
view full post

June 3, 2024

1
pinacol
@pinacol (Twitter)

【RCT】eGFR50-75mL/min/1.73m^2かつ300<UACR<5000mg/gまたは25≤eGFR<50かつ100<UACR<5000のCKDを伴う2型糖尿病患者へのセマグルチド皮下注投与は、プラセボの投与と比較して、主要腎臓イベントリスクを減少させた。 #ペ読 https://t.co/zDeSkchXmn
view full post

June 2, 2024

1
DAMIOPA
@DAMIOPA1 (Twitter)

RT @dr_ukio: ★FLOW試験の結果がERA /NEJMで同時発表されました！ 2型DM+CKD (eGFR 25-75 / UACR 100-5000)　3533人(66歳、アジア24%) セマグルチド注射1.0mg vs プラセボ 3.4年主要複合イベント(…
view full post

June 1, 2024

4
Fizz-DI＠比較と使い分け-KOJIMA Yushi
@Fizz_DI (Twitter)

2型糖尿病患者の慢性腎臓病に対する皮下セマグルチド vs プラセボ（3.4年追跡）・腎疾患イベント：HR=0.71 [95%CI: 0.56-0.89] ・eGFRの低下：年間1.16mL/1.73/m2ほど緩やか N Engl J Med . 2024 May 24. Online ahead of print. PMID:38785209 https://t.co/POYajXr45Y
view full post

May 30, 2024

4
PubMed Trending
@PubTrend (Twitter)

Trending on PubMed: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. https://t.co/uRVMaOFeaN
view full post

May 29, 2024
Katelin Hubbard
@GeneticsJunkie (Twitter)

They also found: - a slower decline in kidney function - 18% lower risk of cardiovascular event - 20% reduced risk of death from any cause https://t.co/HccISZbp7X
view full post

May 28, 2024
青島周一
@syuichiao89 (Twitter)

う〜ん。これも研究デザインの闇よなぁ。複合アウトカムは、イベント発生数で重みづけするべきだと思うんだけど、どう思う？ Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes https://t.co/HuWSMgNnTQ
view full post

May 28, 2024

4
EARLの医学&AIノート
@EARL_med_tw (Twitter)

view full post

May 27, 2024

7
MarcoAntonioMedeiros
@professormarcoa (Twitter)

RT @Mattjones0203: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine http…
view full post

May 27, 2024

1
Endocryne Papers
@Endocryne_reads (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. https://t.co/IgCwu3uW1j
view full post

May 27, 2024
Matt Jones
@Mattjones0203 (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/pIBeo6XU3J
view full post

May 26, 2024

4
1
微生物高貴豬
@bacprotein (Twitter)

@ssrna 感覺現在減肥藥被炒成神藥（好心動？ https://t.co/ntmf8kP7xL
view full post

May 26, 2024
Stephan Schirmer
@StephanSchirme1 (Twitter)

RT @gunnar_heine: Freitag Vormittag #FLOW Samstag Nachmittag #SELECT Renal Sonn-Abend All at HOMe https://t.co/LNfipfiF7d FLOW: https://…
view full post

May 26, 2024

3
marcus_saemann
@MarcusSaemann (Twitter)

RT @gunnar_heine: Freitag Vormittag #FLOW Samstag Nachmittag #SELECT Renal Sonn-Abend All at HOMe https://t.co/LNfipfiF7d FLOW: https://…
view full post

May 26, 2024

3
EOLO MORANDI JR.
@eolojr (Twitter)

RT @gunnar_heine: Freitag Vormittag #FLOW Samstag Nachmittag #SELECT Renal Sonn-Abend All at HOMe https://t.co/LNfipfiF7d FLOW: https://…
view full post

May 26, 2024

3
Gunnar Henrik Heine
@gunnar_heine (Twitter)

Freitag Vormittag #FLOW Samstag Nachmittag #SELECT Renal Sonn-Abend All at HOMe https://t.co/LNfipfiF7d FLOW: https://t.co/OPghOXF94q SELECT Renal: https://t.co/DvGqwctjCn Danke, Professor Johannes Mann! @dgfn_ev @oegnephro @com_SFNDT @MarcusSaemann @dguerrot @AKronbichler https://t.co/pk7lqsmbGP
view full post

May 26, 2024

8
3
Cacci
@cacci5 (Twitter)

RT @dr_ukio: ★FLOW試験の結果がERA /NEJMで同時発表されました！ 2型DM+CKD (eGFR 25-75 / UACR 100-5000)　3533人(66歳、アジア24%) セマグルチド注射1.0mg vs プラセボ 3.4年主要複合イベント(…
view full post

May 25, 2024

4
Marc-Emmanuel Dumas
@MarcEDumas (Twitter)

RT @P_Rossing: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. https://t.co/nt6HOua6ET
view full post

May 25, 2024

3
Passionate Davita
@PassionateDavi1 (Twitter)

RT @dr_ukio: ★FLOW試験の結果がERA /NEJMで同時発表されました！ 2型DM+CKD (eGFR 25-75 / UACR 100-5000)　3533人(66歳、アジア24%) セマグルチド注射1.0mg vs プラセボ 3.4年主要複合イベント(…
view full post

May 24, 2024

4
Dr.U@糖尿病メモ
@dr_ukio (Twitter)

★FLOW試験の結果がERA /NEJMで同時発表されました！ 2型DM+CKD (eGFR 25-75 / UACR 100-5000)　3533人(66歳、アジア24%) セマグルチド注射1.0mg vs プラセボ 3.4年主要複合イベント(透析,移植,eGFR<15, eGFR 50%低下, 腎関連or心血管死亡)は HR 0.76 (0.66～0.88)と低下 https://t.co/mmlZ9JSvG1 https://t.co/XRmTVb45Hw https://t.co/VXRsdeAI3U
view full post

May 24, 2024

30
4
村田悠典 | 医学論文AI総合サイト MVidEra | 論文全文検索AI 開発
@yusuke_m_MU (Twitter)

8. Journal The New England Journal of Medicine **utilizing generative AI: ChatGPT-4o** https://t.co/T5BZMgDqA3
view full post

May 24, 2024

1
Yehuda Handelsman MD FACP, FNLA, FASPC, FAHA, MACE
@YHandelsmanMD (Twitter)

RT @P_Rossing: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. https://t.co/nt6HOua6ET
view full post

May 24, 2024

3
Peter Rossing
@P_Rossing (Twitter)

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. https://t.co/nt6HOua6ET
view full post

May 24, 2024

14
3
Kenar Jhaveri, MD
@kdjhaveri.bsky.social (Bluesky)

Biggest story of 2024 just blasted @NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2403347 -- GLP1RA for CKD with diabetics.. Another win for Nephrology !!!!
view full post

May 24, 2024

Abstract Synopsis

Patients with type 2 diabetes and chronic kidney disease face a high risk of kidney failure, cardiovascular problems, and death, leading to the investigation of semaglutide’s effectiveness in reducing these risks.
In a study involving over 3,500 participants, those receiving semaglutide showed a 24% lower risk of major kidney disease events compared to the placebo group, with significant improvements noted in kidney health and reduced cardiovascular mortality.
The findings indicated that semaglutide not only positively impacted kidney function but also contributed to a slower decline in kidney health compared to the placebo group, supporting its potential benefits for these patients.

Socials: